Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.726,60
0,69%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GeoVax Labs Inc (GOVX) GeoVax Labs Inc (GOVX) Notizie

GeoVax Labs Inc

GOVX
0,00
0,00 (0,00%)
- - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/4/202418:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
28/3/202414:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
12/3/202414:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
11/3/202421:13EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
11/3/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
06/3/202415:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
01/3/202422:08EDGAR2Form S-3 - Registration statement under Securities Act of..
29/2/202422:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
22/2/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
19/2/202415:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
16/2/202422:01EDGAR2Form 8-K - Current report
14/2/202421:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202415:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
07/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
31/1/202419:13EDGAR2Form 8-K - Current report
29/1/202415:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
16/1/202422:03EDGAR2Form 8-K - Current report
12/1/202422:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202415:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
04/1/202415:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
03/1/202415:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
02/1/202422:10EDGAR2Form S-1 - General form for registration of securities under..
27/12/202315:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
26/12/202321:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202315:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
08/12/202322:02EDGAR2Form 8-K - Current report
04/12/202314:00EDGAR2Form 8-K - Current report
30/11/202322:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
29/11/202315:00GLOBEGeoVax to Participate in Upcoming December Investor Events
28/11/202315:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
27/11/202322:06EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202322:27EDGAR2Form PRE 14A - Other preliminary proxy statements
14/11/202315:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
09/11/202318:40EDGAR2Form 8-K - Current report
08/11/202322:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/11/202322:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/11/202322:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
31/10/202314:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
30/10/202314:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
25/10/202315:00GLOBEGeoVax to Participate in Upcoming November Investor and..
24/10/202315:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
09/10/202315:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
05/10/202315:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
27/9/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202315:00GLOBEGeoVax to Participate in Upcoming October Investor and..
Apertura: Min: Max:
Chiusura:

La tua Cronologia

NASDAQ
GOVX
GeoVax Labs
USOTC
NSANF
Nissan Motors (PK)
BIT
F18121
Vontobel Financial Produ...
TG
A3LG02
Voestalpine
TG
PYCP
Minera Alamos
BIT
UIJ154
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network